Stay updated with breaking news from John Nuss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.79) EPS for the quarter, beating the consensus estimate of ($0.87) by $0.08, Briefing.com reports. During the same period last year, the firm earned ($0.62) earnings per share. Ventyx Biosciences Stock Up 27.6 % NASDAQ:VTYX traded up $1.67 during […]
Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.79) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same quarter in the prior year, the business posted ($0.62) earnings per share. Ventyx Biosciences Stock Up 27.6 […]
Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.79) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same quarter last year, the business earned ($0.62) earnings per share. Ventyx Biosciences Stock Performance VTYX stock traded up […]
Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) have received a consensus recommendation of “Hold” from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month […]
Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) insider John Nuss sold 17,628 shares of the company’s stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $2.12, for a total transaction of $37,371.36. Following the completion of the transaction, the insider now directly owns 262,118 shares in […]